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Abstract Rabphilin-3A is a putative target protein for RabfA, a small GTP-binding protein particularly implicated in neurotransmitter release. 
Rabphilin3A interacts more preferentially with GTP-Rcab3A than with GDP-Rab3A. Moreover, Rabphilin-3A shows a weak activity to stimulate 
the GTPase activity of Rab3A and a strong activity to inhibit the Rab3A GTPase-activating protein (GAP)-stimulated GTPase activity of Rab3A. 
Here, we show that Rabphilin-3A has another activity to stimulate the GDP/GTP exchange reaction of Rab3A. Rabphilin-3A may keep Rab3A 
continuously in the GTP-bound form by converting again GDP-Rab3A, which may be converted from GTP-Rab3A by Rab3A GAP, to GTP-Rab3A, 
until the function of Rab3A is accomplished. 
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1. Introduction 
Rabphilin-3A is a putative target protein for Rob3A which 
is implicated in regulated secretion, particularly in neurotrans- 
mitter release ([l-5]; for reviews, see [6,7j). Rabphiliu3A is a 
single polypeptide with a A4, of 77,976 and 704 amino acids 
which interacts preferentially with GTP-Rab3A than with 
GDP-Rub3A [2]. Rabphilin3A has moreover two repeated C2- 
like domains at its C-terminal portion which interacts with Ca” 
and phospholipid, particularly phosphatidylserine [8]. North- 
em and Western blot analyses have revealed that Rabphilin3A 
is specifically expressed in neuron where it is highly concen- 
trated on the synaptic vesicle, although Rabphilin3A lacks a 
transmembrane segment [2,9]. The function of Rabphilin3A 
has not been defined, but our current working model for the 
mode of action of Rab3A and Rabphilin-3A in neurotransmit- 
ter release is as follows: In the resting synapse, GTP-Rub3A 
binds to Rabphilin3A on the synaptic vesicle which is translo- 
cated to the active zone where Ca2+ channel and its accessory 
proteins are clustered. When the presynapse is depolarized and 
Ca” inlluxes into the cytosol, the synaptic vesicle fuses with the 
presynaptic plasma membrane resulting in the neurotransmit- 
ter release into the synaptic cleft. This fusion may be initiated 
by the general docking/fusion machinery of the NSF’SNAP- 
SNARE system ([lo]; for reviews, see [11,12]). The Rub3A- 
Rabphilin-3A system may be involved in translocating and 
targeting the synaptic vesicle to the active zone. Moreover, it 
may serve as an inhibitor for the docking/fusion machinery of 
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the NSF-SNAP-SNARE system as described for synaptotag- 
min ([ 131; for a review, see [ 141). It could be speculated that Ca” 
influxed into the cytosol binds to Rabphilin3A and synapto- 
tagrnin and releases the inhibitory function of these two pro- 
teins, finally allowing the NSF-SNAP-SNARE system to be 
employed. After the fusion, GTP-Rab3A is converted to GDP- 
Rab3A by the action of Rab3A GAP Once GDP-Rab3A is 
produced, its affinity for Rabphihn3A is reduced and more- 
over it becomes complexed with Rab GDI. This complex disso- 
ciates from the membrane to the cytosol. GDP-Rab3A translo- 
cated to the cytosol is converted to GTP-Rab3A by the action 
of Rab3A GRF or MSS4 and it again interacts with Rabphilin- 
3A on the synaptic vesicle. Thus, the RabfA-Rabphilin3A 
system plays an important role in neurotransmitter elease. 
In this model, there may be a mechanism for continuously 
keeping Rab3A in the GTP-bound form until its function is 
accomplished. We have previously found that Rabphilin3A 
potentially has a weak activity to stimulate the intrinsic GTPase 
activity of Rab3A (GAP activity) and a strong activity to inhibit 
the Rab3A GAP-stimulated GTPase activity of Rab3A (GIP 
activity) [15]. These properties of Rabphilin9A are consistent 
with its another biochemical property that it interacts more 
preferentially with GTP-Rab3A than with GDP-Rab3A [2,8]. 
On the basis of these observations, we have proposed that this 
GIP activity may keep Rab3A in the GTP-bound form until its 
function is accomplished, although the physiological function 
of the GAP activity of Rabphilin3A is not known. 
During the course of these studies on Rabphilin3A, we have 
incidentally found that Rabphilin-3A potentially has another 
activity to stimulate the GDP/GTP exchange reaction of 
Rab3A (GEP activity). We will show here this GEP activity of 
Rabphilin3A and also discuss the possible physiological func- 
tion of this GEP activity of Rabphilin3A. 
2. Materials and methods 
2.1. Materials and chemicals 
The post-translationally lipid-modified and lipid-unmodified forms 
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of Rub3A were purified from the membrane and soluble fractions, 
respectively, of Spodoptera frugiperda cells (St9 cells) that were infected 
with the baculovirus carrying the Rab3A cDNA [16]. Rub GDI was 
purified from bovine brain- cytosol as described previously [17]. 
[3sS]GTPyS (44.4 TBqkmnol) was purchased from DuPont-New Eng- 
laud Nuclear. [‘H]GDP (518 GBq/ mmol) was purchased from Amer- 
sham Corp. Nitrocellulose filters (BA-85, 0.45 pm pore size) were ob- 
tained from Schleicher & Schuell. Phosphatidylserine was obtained 
from Serdarv Research Laboratories. A Sunerdex 200 HR 10130 col- 
umn and a Heparin Sepharose CLdB col&n were from Pharmacia 
LKB Biotech Inc. Other materials and chemicals were obtained from 
commercial sources. 
2.2. Expression of Rabphilin-3A in Sp cells and its purification 
The full-length cDNA encoding Rabphilin3A was inserted and ex- 
pressed in St9 cells using the insect/baculovirus system. Rabphilin-3A 
was recovered in the 100,000 x g precipitate and extracted from it by 
2.5% sodium cholate. The extracted protein was purified by Heparin 
Sepharose CL-6B and Superdex 200 HR lo/30 column chromatogra- 
phies as described [18]. 
2.3. Assay for GEP activity 
The GEP activity of Rabphilin-3A was assayed by measuring either 
the dissociation of [‘HjGDP from [‘HJGDP-Rab3A or the binding of 
[‘?S]GTPyS to GDP-Rab3A by the filtration method using nitrocellu- 
lose filters as described previously [19]. 
2.4. Determination 
Protein concentrations were determined with bovine serum albumin 
as a reference protein as described previously [20]. 
3. Results 
Recombinant Rabphilin3A stimulated the dissociation of 
PH]GDP from Rab3A and the binding of [?S]GTP# to Rab3A 
in time- and dose-dependent manners (Figs. 1 and 2). The time 
courses and doses of Rabphilin-3A for these two reactions were 
similar. The dose of Rabphilin3A giving half maximum disso- 
ciation of [3H]GDP from Rab3A was about 0.8 PM and the 
dose of Rabphilin3A giving half maximum binding of 
[35S]GTPyS to Rab3A was also about 0.8 ,uM. The doses of 
Rabphilin-3A necessary for the GEP activity were 5- to lo-fold 
higher than those necessary for the GAP and GIP activities 
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Fig. 1. Effect of Rabphilin-3A on the dissociation of [“HjGDP from Rub3A. (A) Time course. [3H]GDP-Rab3A was incubated for the indicated periods 
of time in the presence or absence of Rabphilin3A (1.6 PM). (o), in the presence of Rabphihn-3A; (0), in the absence of Rabphilin3A. (B) Dose- 
dependent effect of Rabphilin3A. rH]GDP-Rab3A was incubated for 10 min with the indicated amounts of Rabphilin3A. The GEP activity of 
Rabphilin3A was expressed as a decrease in the radioactivity trapped on the nitrocellulose filters in the presence of Rabphilin3A compared with 
that in the absence of Rabphilin3A. The results shown are representative of three independent experiments. 
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described previously [15]. In contrast, Rabphilin-3A did not 
stimulate the dissociation of [35S]GTPyS from Rab3A (data not 
shown). In these experiments, the lipid-modified form of 
Rab3A was used as a substrate for Rabphilin-3A. When the 
lipid-unmodified form of Rab3A was used, Rabphilin- 3A also 
stimulated the dissociation of [3H]GDP from Rab3A, but the 
velocity toward the lipid-unmodified form was about one-third 
of that toward the lipid-modified form (Fig. 3). 
We have shown that Rabphilin3A interacts with Ca*+ and 
phospholipid, particularly acidic phospholipid such as 
phosphatidylserine, at its C terminal portion, which includes 
the CZlike domains [8], and that neither Ca2+ nor phosphati- 
dylserine affects the GAP or GIP activity of Rabphilin-3A [15]. 
Similarly, neither Ca” nor phosphatidylserine affected the 
GEP activity of Rabphilin9A (data not shown). 
We have previously shown that Rab GDI inhibits the disso- 
ciation of [3H]GDP from the lipid-modified form of Rab3A but 
not that from the lipid-unmodified form [21]. Similarly, Rab 
GDI inhibited the Rabphilin-3A-induced dissociation of 
[3H]GDP from the lipid-modified form of Rab3A, but not that 
from the lipid-unmodified form (Fig. 4). 
4. Discussion 
We have shown here that recombinant Rabphilin-3A has not 
only the GAP and GIP activities for Rab3A but also the GEP 
activity for it. Rabphilin-3A interacts with GDP-Rab3A for its 
GEP activity whereas it interacts with GTP--Rub3A for its 
GAP and GIP activities. We have previously shown that 
Rabphilin9A interacts preferentially with GTP-Rab3A but 
also weakly with GDP-Rub3A [2]. This property of Rabphilin- 
3A is consistent with the present result that the doses of 
Rabphilin-3A necessary for its GEP activity are 5- to lo-fold 
higher than those necessary for its GAP and GIP activities. 
We have also shown here that Rabphilin3A is active as a 
GEP for both the lipid-modified and lipid-unmodified forms of 
Rab3A, but prefers the former form to the latter form. We have 
previously shown that one group of GEPs, such as SOS for the 
B 
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Fig. 2. Effect of Rabphilin-3A on the binding of [%]GTPyS to Rab3A. (A) Time course.. Rab3A was incubated witb [%]GTPyS for the indicated 
periods of time in the presence or absence of Rabphilin-3A (1.6 PM). (e), in the presence of Rabphilin-3A; (0), in the absence of Rabphilin-3A. 
(B) Dose-dependent effect of Rabphilin-3A. Rub3A was incubated with [3’S]GTPyS for 10 min with the indicated amounts of Rabphilin-3A. The 
GEP activity of Rabphilin-3A was expressed asan increase in the radioactivity trapped on the nitrocellulose filters in the presence ofRabphilin-3A 
compared with that in the absence of Rabphilin-3A. The results hown are representative of three independent experiments. 
Rus family members [22], Cdc25 for the Rus family members 
[23], Dbl for the Rho family members, the Rat family members, 
and Cdc42 [24], and Rab3A GRF for Rab3A [25], are active on 
both the lipid-modified and lipid-unmodified forms of their 
respective substrate small G proteins but prefer much more the 
former form to the latter form, whereas another group of 
GEPs, such as Smg GDS for Ki-Ras, Rapl, the Rho family 
members, the Rut family members, and Cdc42 [24,26,27], Rho 
GDI for the Rho family members, the Rat family members, and 
Cdc42 [27,28], and Rab GDI for the Rab family members [21], 
absolutely require the lipid-modifications of their respective 
substrate small G proteins and are completely inactive on the 
lipid-unmodified form. In addition to these two groups of 
GEPs, we have recently shown that MSS4 is equally active on 
both the lipid-modified and lipid-unmodified forms of Rub3A 
WI- 
We have previously shown that Rab GDI inhibits the Rab3A 
GRF-induced GDP/GTP exchange reaction of the lipid-modi- 
fied form of Rab3A but not that of the lipid-unmodified form 
[25]. We have recently shown that Rab GDI inhibits the MS% 
induced GDP/GTP exchange reaction of the lipid-modified 
form of Rab3A but not that of the lipid-unmodified form [19]. 
Consistent with these observations, we have shown here that 
Rub GDI inhibits the GEP activity of Rabphilin3A for the 
lipid-modified form of Rab3A, but not that for the lipid-un- 
modified form. 
Rabphilin-3A has two repeated CZlike domains and inter- 
acts with Ca2+ and phospholipid, particularly acidic phospho- 
lipid such as phosphatidylserine, at these domains [8]. We have 
previously reported that neither Ca’+ nor phosphatidylserine 
affects the GAP or GIP activity of Rabphilin-3A [15]. We have 
shown here that neither Ca” nor phosphatidylserine affects the 
GEP activity of Rabphilin-3A. The physiological function of 
CZlike domains of Rabphilin-3A still remains unknown. 
Finally, what is the physiological function of the GEP activ- 
ity of Rabphilin3A? One possibility is that this GEP activity 
of Rabphilin-3A is an artifact just due to the physicochemical 
property. Another possibility is that the GEP activity of 
Rabphilin3A functions under particular conditions. It could 
be speculated that Rab3A should be continuously kept in the 
GTP-bound form until its function is accomplished. For this 
purpose, GTP-Rab3A complexed with Rabphilin-3A may be 
protected from Rub3A GAP by the GIP activity of Rabphilin- 
3A. However, it would be possible that GTP-Rab3A may be 
converted to GDP-Rab3A by the action of Rab3A GAP or the 
intrinsic GAP activity of Rabphilin3A before its function is 
accomplished. When this event occurs, Rabphilin3A may 
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Fig. 3. The GEP activity of Rabphilin-3A for the lipid-modified and 
lipid-unmodikd forms of Rub3A. The lipid-mod&d or lipid-unmod- 
ified form of [‘HjGDP-Rub3A was incubated for 10 min in the presence 
of the indicated amounts of Rabphilin-3A. (o), the lipid-modified form; 
(o), the lipid-unmodified form. The results shown are representative of
three independent experiments. 
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Fig. 4. Effect of Rab GDI on the GEP activity of Rabphilin3A. The lipid-modified or lipid-unmodified form of [3H]GDP-Rab3A was incubated 
for 10 min with the indicated amounts of Rub GDI in the presence or absence of Rabphilin3A (1.6 ,uM). (A) The lipid-modified form; (B), the 
lipid-umnodiied form. (o), in the presence of Rabphilin-3A; (0), in the absence of Rabphilin-3A. The results shown are representative of three 
independent experiments. 
again return GDP-Rab3A to GTP-Rab3A by its intrinsic GEP 
activity before GDP-Rub3A becomes complexed with Rub 
GDI. Thus, Rabphilin-3A may possess the intrinsic GEP activ- 
ity as a self-guarantee for keeping Rab3A in the GTP-bound 
form. Further studies are essential for understanding the phys- 
iological significance of the GEP, GAP, and GIP activities of 
Rabphilin3A. 
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